Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simpl...

Full description

Saved in:
Bibliographic Details
Main Authors: Gustav Schellack, J. C. Meyer, Natalie Schellack
Format: Article
Language:English
Published: AOSIS 2016-03-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4468
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234152651489280
author Gustav Schellack
J. C. Meyer
Natalie Schellack
author_facet Gustav Schellack
J. C. Meyer
Natalie Schellack
author_sort Gustav Schellack
collection DOAJ
description Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.
format Article
id doaj-art-60913e09d28044a2b77d4f7b177359b6
institution Kabale University
issn 2078-6190
2078-6204
language English
publishDate 2016-03-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj-art-60913e09d28044a2b77d4f7b177359b62025-08-20T04:03:13ZengAOSISSouth African Family Practice2078-61902078-62042016-03-0158210.4102/safp.v58i2.44683615Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment optionsGustav Schellack0J. C. Meyer1Natalie Schellack2Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University (SMU)Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University (SMU)Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University (SMU)Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.https://safpj.co.za/index.php/safpj/article/view/4468gordgastro-oesophageal refluxppisproton-pump inhibitorscost-effectiveness
spellingShingle Gustav Schellack
J. C. Meyer
Natalie Schellack
Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
South African Family Practice
gord
gastro-oesophageal reflux
ppis
proton-pump inhibitors
cost-effectiveness
title Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
title_full Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
title_fullStr Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
title_full_unstemmed Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
title_short Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
title_sort gastro oesophageal reflux an overview of the cost effectiveness of pharmacotherapeutic treatment options
topic gord
gastro-oesophageal reflux
ppis
proton-pump inhibitors
cost-effectiveness
url https://safpj.co.za/index.php/safpj/article/view/4468
work_keys_str_mv AT gustavschellack gastrooesophagealrefluxanoverviewofthecosteffectivenessofpharmacotherapeutictreatmentoptions
AT jcmeyer gastrooesophagealrefluxanoverviewofthecosteffectivenessofpharmacotherapeutictreatmentoptions
AT natalieschellack gastrooesophagealrefluxanoverviewofthecosteffectivenessofpharmacotherapeutictreatmentoptions